These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 19248780)

  • 21. Analysis of somatic APC mutations in rare extracolonic tumors of patients with familial adenomatous polyposis coli.
    Bläker H; Sutter C; Kadmon M; Otto HF; Von Knebel-Doeberitz M; Gebert J; Helmke BM
    Genes Chromosomes Cancer; 2004 Oct; 41(2):93-8. PubMed ID: 15287021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severe polyposis in Apc(1322T) mice is associated with submaximal Wnt signalling and increased expression of the stem cell marker Lgr5.
    Lewis A; Segditsas S; Deheragoda M; Pollard P; Jeffery R; Nye E; Lockstone H; Davis H; Clark S; Stamp G; Poulsom R; Wright N; Tomlinson I
    Gut; 2010 Dec; 59(12):1680-6. PubMed ID: 20926645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of Icat induces G(2) arrest and cell death in tumor cell mutants for adenomatous polyposis coli, beta-catenin, or Axin.
    Sekiya T; Nakamura T; Kazuki Y; Oshimura M; Kohu K; Tago K; Ohwada S; Akiyama T
    Cancer Res; 2002 Jun; 62(11):3322-6. PubMed ID: 12036951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of intestinal polyposis with reduced angiogenesis in ApcMin/+ mice due to decreases in c-Myc expression.
    Yekkala K; Baudino TA
    Mol Cancer Res; 2007 Dec; 5(12):1296-303. PubMed ID: 18171987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. APC inactivation associates with abnormal mitosis completion and concomitant BUB1B/MAD2L1 up-regulation.
    Abal M; Obrador-Hevia A; Janssen KP; Casadome L; Menendez M; Carpentier S; Barillot E; Wagner M; Ansorge W; Moeslein G; Fsihi H; Bezrookove V; Reventos J; Louvard D; Capella G; Robine S
    Gastroenterology; 2007 Jun; 132(7):2448-58. PubMed ID: 17570218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different APC genotypes in proximal and distal sporadic colorectal cancers suggest distinct WNT/β-catenin signalling thresholds for tumourigenesis.
    Christie M; Jorissen RN; Mouradov D; Sakthianandeswaren A; Li S; Day F; Tsui C; Lipton L; Desai J; Jones IT; McLaughlin S; Ward RL; Hawkins NJ; Ruszkiewicz AR; Moore J; Burgess AW; Busam D; Zhao Q; Strausberg RL; Simpson AJ; Tomlinson IP; Gibbs P; Sieber OM
    Oncogene; 2013 Sep; 32(39):4675-82. PubMed ID: 23085758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inactivation of Apc in the mouse prostate causes prostate carcinoma.
    Bruxvoort KJ; Charbonneau HM; Giambernardi TA; Goolsby JC; Qian CN; Zylstra CR; Robinson DR; Roy-Burman P; Shaw AK; Buckner-Berghuis BD; Sigler RE; Resau JH; Sullivan R; Bushman W; Williams BO
    Cancer Res; 2007 Mar; 67(6):2490-6. PubMed ID: 17363566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. APC mutations in FAP-associated desmoid tumours are non-random but not 'just right'.
    Latchford A; Volikos E; Johnson V; Rogers P; Suraweera N; Tomlinson I; Phillips R; Silver A
    Hum Mol Genet; 2007 Jan; 16(1):78-82. PubMed ID: 17135276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional characterization of the novel APC N1026S variant associated with attenuated familial adenomatous polyposis.
    Menéndez M; González S; Obrador-Hevia A; Domínguez A; Pujol MJ; Valls J; Canela N; Blanco I; Torres A; Pineda-Lucena A; Moreno V; Bachs O; Capellá G
    Gastroenterology; 2008 Jan; 134(1):56-64. PubMed ID: 18166348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Guanylyl cyclase C suppresses intestinal tumorigenesis by restricting proliferation and maintaining genomic integrity.
    Li P; Schulz S; Bombonati A; Palazzo JP; Hyslop TM; Xu Y; Baran AA; Siracusa LD; Pitari GM; Waldman SA
    Gastroenterology; 2007 Aug; 133(2):599-607. PubMed ID: 17681179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A role for the vitamin D pathway in non-intestinal lesions in genetic and carcinogen models of colorectal cancer and in familial adenomatous polyposis.
    Bong YS; Assefnia S; Tuohy T; Neklason DW; Burt RW; Ahn J; Bueno De Mesquita PJ; Byers SW
    Oncotarget; 2016 Dec; 7(49):80508-80520. PubMed ID: 27768599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crypt-restricted proliferation and commitment to the Paneth cell lineage following Apc loss in the mouse intestine.
    Andreu P; Colnot S; Godard C; Gad S; Chafey P; Niwa-Kawakita M; Laurent-Puig P; Kahn A; Robine S; Perret C; Romagnolo B
    Development; 2005 Mar; 132(6):1443-51. PubMed ID: 15716339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcriptional profiling of the transition from normal intestinal epithelia to adenomas and carcinomas in the APCMin/+ mouse.
    Paoni NF; Feldman MW; Gutierrez LS; Ploplis VA; Castellino FJ
    Physiol Genomics; 2003 Nov; 15(3):228-35. PubMed ID: 13130079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.
    Satoh S; Daigo Y; Furukawa Y; Kato T; Miwa N; Nishiwaki T; Kawasoe T; Ishiguro H; Fujita M; Tokino T; Sasaki Y; Imaoka S; Murata M; Shimano T; Yamaoka Y; Nakamura Y
    Nat Genet; 2000 Mar; 24(3):245-50. PubMed ID: 10700176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors).
    Alman BA; Li C; Pajerski ME; Diaz-Cano S; Wolfe HJ
    Am J Pathol; 1997 Aug; 151(2):329-34. PubMed ID: 9250146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cooperation between the thyroid hormone receptor TRalpha1 and the WNT pathway in the induction of intestinal tumorigenesis.
    Kress E; Skah S; Sirakov M; Nadjar J; Gadot N; Scoazec JY; Samarut J; Plateroti M
    Gastroenterology; 2010 May; 138(5):1863-74. PubMed ID: 20114049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling.
    Moon BS; Jeong WJ; Park J; Kim TI; Min do S; Choi KY
    J Natl Cancer Inst; 2014 Feb; 106(2):djt373. PubMed ID: 24491301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis.
    Ito K; Lim AC; Salto-Tellez M; Motoda L; Osato M; Chuang LS; Lee CW; Voon DC; Koo JK; Wang H; Fukamachi H; Ito Y
    Cancer Cell; 2008 Sep; 14(3):226-37. PubMed ID: 18772112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beta-catenin expression and allelic loss at APC in sporadic colorectal carcinogenesis.
    Hao X; Frayling IM; Willcocks TC; Han W; Tomlinson IP; Pignatelli MN; Pretlow TP; Talbot IC
    Virchows Arch; 2002 Apr; 440(4):362-6. PubMed ID: 11956815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Large-scale N-terminal deletions but not point mutations stabilize beta-catenin in small bowel carcinomas, suggesting divergent molecular pathways of small and large intestinal carcinogenesis.
    Breuhahn K; Singh S; Schirmacher P; Bläker H
    J Pathol; 2008 Jul; 215(3):300-7. PubMed ID: 18491352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.